The EMA is already studying updated vaccines in order to better respond to the new sub-variables

Preventive medicine and public health


The first approvals of these “renewed vaccines” will arrive in September and are expected to have activity against the BA4 and BA5 variants, which are responsible for a slight recovery.

EMA warns that a rebound in SARS-CoV-2 infection has recently been observed in some European countries, in most cases due to the prevalence of BA4 and BA5 sub variants.

Leave a Comment